Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,214Inspections Most recent open 2026-07-16 Last loaded 2026-07-20

OSHA Inspection: WESTERN INFECTIOUS DISEASE CONSULTANTS, PC

Complaint inspection · Health discipline

On , OSHA opened a complaint health inspection of WESTERN INFECTIOUS DISEASE CONSULTANTS, PC in 3303 W. 144TH AVE. #103, BROOMFIELD, CO 80023 (NAICS 621111). OSHA activity number 343181012.

Watch Western Infectious Disease Consultants, PC — free Get an email when a new federal OSHA severe-injury report for Western Infectious Disease Consultants, PC is published. One employer, no account, unsubscribe in one click.
Site address
3303 W. 144TH AVE. #103
City
BROOMFIELD
State
CO
ZIP
80023
Mailing
3303 W. 144TH AVE. #103, BROOMFIELD, CO 80023
Inspection type
Complaint (B)
Scope
Partial (B)
Discipline
Health
Advance notice
No
Union status
B
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
621111
Employees
9
Ownership type
A

6 citations on file for this inspection.

1910.1200 E01

Serious Gravity 1 1 instance 40 exposed
Issued
Abate by
Penalty
Initial $3298.00 · Current $2000.00 Reduced
29 CFR 1910.1200(e)(1): Employer had not developed, implemented or maintained at each workplace, a written hazard communication program which at least describes how the criteria specified in paragraphs (f), (g) and (h) of this section for labels and other forms of warning, safety data sheets, and employee information and training will be met:      (a) Western Infectious Disease Consultants, PC at 3303 W 144th Ave, #103 in Broomfield, Colorado:  On or before May 24, 2018, the employer did not develop and implement a written hazard communication program that pertains to employee use of chemicals such as, but not limited to the following.  This condition exposed employees to chemical exposure hazards:      1)    Povidone-Iodine swabs and prep pads  2)    Prevanti x maxi swab stick  3)    Maxispray plus, Maxicide plus, Maxicide  4)    Chlorascrub swab, swabstick and maxistick  5)    Chloraprep 2.0%  6)    Caviwipes, Cavicide  7)    Alcavis bleach wipes 1:10  8)    Betadine  9)    Biopathc with CHR   10)  Isopropyl alcohol
Recent events (2)
  • — I (S) $2000
  • — Z (S) $3298

1910.1200 H01

Serious Gravity 1 1 instance 40 exposed
Issued
Abate by
Penalty
Initial $0.00 · Current $0.00
29 CFR 1910.1200(h)(1): Employer had not provided employees with effective information and training on hazardous chemicals in their work area at the time of their initial assignment, and whenever a new chemical hazard the employees had not previously been trained about was introduced into their work area:      (a) Colorado Health Providers, LLC dba Colorado Clinic at 3810 N Grant Ave in Loveland, Colorado:  On or before April 27, 2018, the employer did not provide employees with effective information and training on hazardous chemicals in their work area at the time of their initial assignment, and whenever a new physical or health hazard the employees have not previously been trained about is introduced into their work area, such as but not limited to the following.  This condition exposed employees to chemical exposure hazards:    1)    Povidone-Iodine swabs and prep pads  2)    Prevanti x maxi swab stick  3)    Maxispray plus, Maxicide plus, Maxicide  4)    Chlorascrub swab, swabstick and maxistick  5)    Chloraprep 2.0%  6)    Caviwipes, Cavicide  7)    Alcavis bleach wipes 1:10  8)    Betadine  9)    Biopathc with CHR   10)  Isopropyl alcohol
Recent events (2)
  • — I (S) $0
  • — Z (S) $0

1910.1030 C01 I

Other-than-serious 1 instance 40 exposed
Issued
Abate by
Penalty
Initial $0.00 · Current $0.00
29 CFR 1910.1030(c)(1)(i):  The employer had not established a written Exposure Control Plan designed to eliminate or minimize employee occupational exposure to bloodborne pathogens:      (a) Western Infectious Disease Consultants, PC at 3303 W 144th Ave, #103 in Broomfield, Colorado:  On or before May 24, 2018, the employer, having employees with occupational exposure, did not established a written Exposure Control Plan designed to eliminate or minimize employee exposure, in that employees were expected and required as part of their job duties to see patients, administer medications, and clean up patient rooms after treatment that could involve blood or other potentially infectious materials.        NOTE:  The Exposure Control Plan shall contain at least the following elements:      1) The exposure determination required by paragraph (c)(2);  2) The schedule and method of implementation for paragraphs:    (d) Methods of Compliance,    (f) Hepatitis B Vaccination and Post-Exposure Evaluation and Follow-up,    (g) Communication of Hazards to Employees, and    (h) Recordkeeping, of this standard;  3) The procedure for the evaluation of circumstances surrounding exposure incidents as required by paragraph (f)(3)(i) of this standard.
Recent events (2)
  • — I (O) $0
  • — Z (O) $0

1910.1030 C01 IV

Other-than-serious 1 instance 40 exposed
Issued
Abate by
Penalty
Initial $0.00 · Current $0.00
29 CFR 1910.1030(c)(1)(iv): The employer did not review or update the Exposure Control Plan at least annually and whenever necessary to reflect new or modified tasks and procedures which affect occupational exposure and to reflect new or revised employee positions with occupational exposure. The review and update of such plans did not also reflect changes in technology that eliminate or reduce exposure to bloodborne pathogens; and did not document annually consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure.    a) Western Infectious Disease Consultants, PC at 3303 W 144th Ave, #103 in Broomfield, Colorado:  On or before May 24, 2018, the employer, having employees with occupational exposure, did not review or update the Exposure Control Plan and review any technology that eliminate or reduce exposure to bloodborne pathogens; and did not document annually consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure. The written Exposure Control Plan was not reviewed annually to eliminate or minimize employee exposure, in that employees were expected and required as part of their job duties to clean up patient rooms after treatment that could involve blood or other potentially infectious materials.
Recent events (2)
  • — I (O) $0
  • — Z (O) $0

1910.1030 F01 II B

Deleted Other-than-serious 1 instance 40 exposed
Issued
Abate by
Penalty
Initial $0.00 · Current $0.00
29 CFR 1910.1030(f)(1)(ii)(B): The employer did not ensure that all medical evaluations or procedures including the hepatitis B vaccine, vaccination series, post-exposure evaluation, or follow-up, including prophylaxis, were made available to employees at a reasonable time and place:  (a) Western Infectious Disease Consultants, PC at 3303 W 144th Ave, #103 in Broomfield, Colorado:  On or before May 24, 2018, the employer, having employees with occupational exposure, did not make available the hepatitis B vaccination available after employees had received the training required in 29 CFR 1910.1030(g)(2)(vii)(I) and within 10 working days of initial assignment.
Recent events (2)
  • — I (O) $0
  • — Z (O) $0

1910.1030 G02 I

Other-than-serious 1 instance 40 exposed
Issued
Abate by
Penalty
Initial $0.00 · Current $0.00
29 CFR 1910.1030(g)(2)(i):  The employer did not ensure that each employee with occupational exposure participated in a training program in accordance with the requirements of the section:      (a) Western Infectious Disease Consultants, PC at 3303 W 144th Ave, #103 in Broomfield, Colorado:  On or before May 24, 2018, the employer, did not ensure that each employee with occupational exposure to blood borne pathogens participated in a training program in accordance with all requirements of the section.  Employees, as part of their job duties, cleaned patient rooms, analyzed urine samples, and spills of blood or other potentially infectious materials.  This condition exposed employees to a bloodborne pathogen hazard.      Abatement Note:  Training shall be provided as follows:      1)      At the time of initial assignment to tasks where occupational exposure may take place;  2)      Within 90 days after the effective date of the standard; and  3)      At least annually thereafter.  4)      The training program shall contain at a minimum the following elements:    (a)   An accessible copy of the regulatory text of this standard and an explanation of its contents;    (b)   A general explanation of the epidemiology and symptoms of bloodborne diseases;    (c)   An explanation of the modes of transmission of bloodborne pathogens;    (d)   An explanation of the employer's exposure control plan and the means by which the employee can obtain a copy of the written plan;    (e)   An explanation of the appropriate methods for recognizing tasks and other activities that may involve exposure to blood and other potentially infectious materials;    (f)    An explanation of the use and limitations of methods that will prevent or reduce exposure including appropriate engineering controls, work practices, and personal    (g)   protective equipment;    (h)   Information on the types, proper use, location, removal, handling, decontamination and disposal of personal protective equipment;    (i)     An explanation of the basis for selection of personal protective equipment;    (j)     Information on the hepatitis B vaccine, including information on its efficacy, safety, method of administration, the benefits of being vaccinated, and that the vaccine and vaccination will be offered free of charge;    (k)   Information on the appropriate actions to take and persons to contact in an emergency involving blood or other potentially infectious materials;    (l)     An explanation of the procedure to follow if an exposure incident occurs, including the method of reporting the incident and the medical follow-up that will be made available; Information on the post-exposure evaluation and follow-up that the employer is required to provide for the employee following an exposure incident;    (m) An explanation of the signs and labels and/or color coding required by paragraph (g)(1); and    (n)   An opportunity for interactive questions and answers with the person conducting the training session.
Recent events (2)
  • — I (O) $0
  • — Z (O) $0

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 343181012.